Wu Xiaoyu, Liu Wentao, Tang Ding, Xiao Haijuan, Wu Zhenfeng, Chen Che, Yao Xuequan, Liu Fukun, Li Gang
Department of Surgical Oncology, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing 210029, P.R. China.
Department of Surgery, Ruijin Hospital, Shanghai Jiaotong University, Shanghai Institute of Digestive Surgery, Shanghai 200025, P.R. China.
Sci Rep. 2016 Jul 1;6:28044. doi: 10.1038/srep28044.
Notch ligands and receptors are frequently deregulated in several human malignancies including gastric cancer. The activation of Notch signaling has been reported to contribute to gastric carcinogenesis and progression. However, the prognostic roles of individual Notch receptors in gastric cancer patients remain elusive. In the current study, we accessed the prognostic roles of four Notch receptors, Notch 1-4, in gastric cancer patients through "The Kaplan-Meier plotter" (KM plotter) database, in which updated gene expression data and survival information include a total of 876 gastric cancer patients. All four Notch receptors' high mRNA expression was found to be correlated to worsen overall survival (OS) for all gastric cancer patients followed for 20 years. We further accessed the prognostic roles of individual Notch receptors in different clinicopathological features using Lauren classification, pathological grades, clinical grades, HER2 status and different choices of treatments of gastric cancer patients. These results indicate that there are critical prognostic values of the four Notch receptors in gastric cancer. This information will be useful for better understanding of the heterogeneity and complexity in the molecular biology of gastric cancer and to develop tools to more accurately predict their prognosis.
Notch配体和受体在包括胃癌在内的多种人类恶性肿瘤中经常失调。据报道,Notch信号通路的激活有助于胃癌的发生和发展。然而,单个Notch受体在胃癌患者中的预后作用仍不清楚。在本研究中,我们通过“The Kaplan-Meier plotter”(KM plotter)数据库评估了四种Notch受体(Notch 1-4)在胃癌患者中的预后作用,该数据库中更新的基因表达数据和生存信息总共包括876例胃癌患者。发现所有四种Notch受体的高mRNA表达与随访20年的所有胃癌患者的总生存期(OS)恶化相关。我们进一步使用劳伦分类、病理分级、临床分级、HER2状态以及胃癌患者不同的治疗选择评估了单个Notch受体在不同临床病理特征中的预后作用。这些结果表明,这四种Notch受体在胃癌中具有关键的预后价值。这些信息将有助于更好地理解胃癌分子生物学中的异质性和复杂性,并开发工具以更准确地预测其预后。